Our mission is to develop herpesvirus-based animal vaccines to protect against infectious diseases. 

Vaccine Solutions for the 21st Century

The Vaccine Group (TVG) is using recombinant viral vector technology to develop new vaccines for use in animals, including:

  • Diseases such as Streptococcus suis, bovine tuberculosis, porcine reproductive & respiratory syndrome and African swine fever, which have a high impact on production of economically important livestock;
  • Diseases in wildlife such as Ebola and Lassa fever, which jump from animals into humans.


Piglet being held whilst waiting for vaccination

Our Pipeline

We are creating vaccine delivery platforms for viral and bacterial pathogens to address a growing number of diseases in animals:

Streptococcus suis
• Porcine reproductive and respiratory syndrome (PRRS)
• Porcine circovirus-2
• Porcine cysticercosis
• Bovine tuberculosis
• Bovine bacterial mastitis
• Bovine respiratory syncytial virus
• African swine fever 
• Lumpy skin disease

Leadership Team


Jeremy Salt, PhD


Michael Jarvis, PhD

Founder & CSO

Matthew White Profile

Matthew White


Prof. Robert Fern


Latest News